Market Tracker

08/24 6:28am ET

Novo Nordisk A/S (NYSE:NVO)

45.37
Delayed Data
As of Aug 23
 -0.78 / -1.69%
Today’s Change
30.89
Today|||52-Week Range
47.75
+26.52%
Year-to-Date

Today’s Trading

Previous close46.15
Today’s open45.63
Day’s range45.29 - 45.79
Volume1,855,663
Average volume (3 months)2,018,942
Market cap$90.8B
Dividend yield2.09%
Data as of 08/23/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.51%
Revenue growth (last year)+3.81%
P/E ratio2.9
Price/Sales5.48
Price/Book18.00

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.20+0.35%
ABTAbbott Laboratories-0.07-0.14%
LLYEli Lilly and Co-0.11-0.14%
GSKGlaxoSmithKline+0.19+0.49%
Data as of 08/23/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.59
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts